Press Release
All the Latest Press Releases
2024
Oct
PATIENTVIEW – MENTAL-HEALTH EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Sep
新闻稿: 2023/4年患者团体对制药企业的评价——亚洲版
プレスリリース: 2023年4月の製薬業界について患者団体が語ること-アジア編
PATIENTVIEW – ASIA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Aug
PATIENTVIEW – RARE-DISEASE EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press release
Jul
COMUNICADO DE PRENSA – PATIENTVIEW – EDICIÓN PARA ESPAÑA: LA REPUTACIÓN EMPRESARIAL DE LA INDUSTRIA FARMACÉUTICA DE 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – SPAIN EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – FRANCE EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releaseCOMMUNIQUÉ DE PRESSE – PATIENTVIEW – ÉDITION FRANCE : LA RÉPUTATION CORPORATIVE DE LA PHARMA 2023/4
Read this press releaseCOMUNICATO STAMPA – PATIENTVIEW – EDIZIONE ITALIA: LA CORPORATE REPUTATION OF PHARMA 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – ITALY EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESSEMITTEILUNG – PATIENTVIEW – DEUTSCHLANDAUSGABE: DIE UNTERNEHMENSREPUTATION VON PHARMA 2023/4
Read this press release
Jun
PRESS RELEASE – PATIENTVIEW – GERMANY EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – CANCERS: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – CANCER EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press release
May
PRESS RELEASE – PATIENTVIEW – CANADA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – UK EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press releasePRESS RELEASE – PATIENTVIEW – USA EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
Read this press release
Apr
PRESS RELEASE – PATIENTVIEW – GLOBAL EDITION: THE CORPORATE REPUTATION OF PHARMA IN 2023/4
2023
Nov
PRESS RELEASE – PATIENT VIEW – PHARMA AND ESG: THE PATIENT PERSPECTIVE 2023 (FOR PATIENT GROUPS)
Read this press release